ClinicalTrials.Veeva

Menu

Characterization of Low Density Lipoprotein and Mechanism of the Pro Aggregant Effect Through Oxidant Stress and Lipid Exchange (ECLIPSE)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Diabetes
Metabolic Syndrome

Treatments

Procedure: Blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT00932087
2008.516

Details and patient eligibility

About

Case control design: lipidomic study in 12 type 2 diabetics with metabolic syndrome, 12 metabolic syndrome without diabetes, 12 subjects with type 1 diabetes and 12 controls

Enrollment

48 estimated patients

Sex

Male

Ages

30 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • statin and fibrate Wash out for one week
  • HbA1c>7% and <12% (Arms 1 and 3)
  • HbA1c<6% (Arms 2 and 4)
  • Metabolic sd according NCEP III (3 out 4 criteria) (Arms 1 and 2)

Exclusion criteria

  • secondary CV prevention

Trial design

48 participants in 4 patient groups

type 2 diabetics with metabolic syndrome
Treatment:
Procedure: Blood sample
metabolic syndrome without diabetes
Treatment:
Procedure: Blood sample
type 1 diabetes
Treatment:
Procedure: Blood sample
control
Treatment:
Procedure: Blood sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems